Joanne Laurette Billings MD
Critical Care Medicine, Pleural Disease
Associate Professor, Medicine, University of Minnesota Medical School
Join to View Full Profile
909 Fulton Ave. SEM Health Fairview CSCMinneapolis, MN 55455
Phone+1 612-273-8383
Dr. Billings is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 2000- University of MinnesotaResidency, Internal Medicine, 1992 - 1995
Rush Medical College of Rush University Medical CenterClass of 1992
Certifications & Licensure
MN State Medical License 1994 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. Start of enrollment: 2006 Mar 01
- A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. Start of enrollment: 2006 Feb 01
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAttitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulators.Nora Burdis, Siddhartha G Kapnadak, Lauren E Bartlett, Oliver McElvaney, Tijana Milinic
BMC Pulmonary Medicine. 2024-07-18 - Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis.Kathleen Mahan, Sarah Kiel, Rebecca Freese, Nicholas Marka, Jordan Dunitz
Heliyon. 2024-03-30 - 2 citationsAssessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor.David Nichols, Alex Gifford, Renee Russell, Katherine Odem-Davis, Julia Young
Annals of the American Thoracic Society. 2024-02-01
Journal Articles
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Victor Tapson, Daniel A Sweeney, Richard A Mularski, Alpesh N Amin, Joanne Billings, Marie-Carmelle Elie, The New England Journal of Medicine
Grant Support
- Multidose Safety And Tolerability Study Of Liposomal Amikacin For Inhalation (ArNational Center For Research Resources2009
- Kb001-03: A Phase I/II Randomized, Double-Blind, Placebo-Controlled, Single-DoseNational Center For Research Resources2009
- Expanded Access Program For Aztreonamn Lysine For Inhalation In Patients With CYNational Center For Research Resources2009
- Inhaled Sodium Pyruvate For The Treatment Of Cystic Fibrosis A Phase I, DoubleNational Center For Research Resources2008
- A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial WithNational Center For Research Resources2008
- Women'S Health In Cystic FibrosisNational Center For Research Resources2004–2007
- A Phase II, Randomized, Double Blind, Parallel Dose Study Of Oral Theraclec-TotaNational Center For Research Resources2005–2006
- Women'S Health In Cystic FibrosisNational Heart, Lung, And Blood Institute2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
